{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:15:40Z","timestamp":1790871340154,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,7,13]],"date-time":"2006-07-13T00:00:00Z","timestamp":1152748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,7,13]],"date-time":"2006-07-13T00:00:00Z","timestamp":1152748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2006,9,1]]},"DOI":"10.1038\/sj.leu.2404320","type":"journal-article","created":{"date-parts":[[2006,7,13]],"date-time":"2006-07-13T09:38:28Z","timestamp":1152783508000},"page":"1526-1532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study"],"prefix":"10.1038","volume":"20","author":[{"given":"A","family":"Delannoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Delabesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Lh\u00e9ritier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Castaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Rigal-Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Raffoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Garban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bologna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Dubruille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Turlure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Reman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Delain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Isnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Coso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Raby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Buzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Caill\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Darre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Fohrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bilhou-Nabera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"B\u00e9n\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Dombret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Berthaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,7,13]]},"reference":[{"key":"BF2404320_CR1","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1182\/blood-2002-03-0704","volume":"100","author":"H Dombret","year":"2002","unstructured":"Dombret H, Gabert J, Boiron JM, Rigal-Huguet F, Blaise D, Thomas X et al. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: results of the prospective multicenter LALA-94 trial. Blood 2002; 100: 2357\u20132366.","journal-title":"Blood"},{"key":"BF2404320_CR2","doi-asserted-by":"crossref","unstructured":"Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Fran\u00e7ais de Cytogenetique Hematologique. Blood 1996; 87: 3135\u20133142.","DOI":"10.1182\/blood.V87.8.3135.bloodjournal8783135"},{"key":"BF2404320_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/10245330400001983","volume":"9","author":"R Houot","year":"2004","unstructured":"Houot R, Tavernier E, Le QH, Lheritier V, Thiebaut A, Thomas X . Philadelphia chromosome-positive acute lymphoblastic leukemia in the elderly: prognostic factors and treatment outcome. Hematology 2004; 9: 369\u2013976.","journal-title":"Hematology"},{"key":"BF2404320_CR4","first-page":"139","volume":"295","author":"E Buchdunger","year":"2000","unstructured":"Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000; 295: 139\u2013145.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF2404320_CR5","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1182\/blood-2001-12-0181","volume":"100","author":"OG Ottmann","year":"2002","unstructured":"Ottmann OG, Druker BJ, Sawyers CL, Goldman JM, Reiffers J, Silver RT et al. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood 2002; 100: 1965\u20131971.","journal-title":"Blood"},{"key":"BF2404320_CR6","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1182\/blood-2004-04-1389","volume":"104","author":"M Towatari","year":"2004","unstructured":"Towatari M, Yanada M, Usui N, Takeuchi J, Sugiura I, Takeuchi M et al. Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia. Blood 2004; 104: 3507\u20133512.","journal-title":"Blood"},{"key":"BF2404320_CR7","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1182\/blood-2003-08-2958","volume":"103","author":"DA Thomas","year":"2004","unstructured":"Thomas DA, Faderl S, Cortes J, O'Brien S, Giles FJ, Kornblau SM et al. Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood 2004; 103: 4396\u20134407.","journal-title":"Blood"},{"key":"BF2404320_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/10428190210180","volume":"43","author":"A Delannoy","year":"2002","unstructured":"Delannoy A, Cazin B, Thomas X, Bouabdallah R, Boiron JM, Huguet F et al. Treatment of acute lymphoblastic leukemia in the elderly: an evaluation of interferon alpha given as a single agent after complete remission. Leuk Lymphoma 2002; 43: 75\u201381.","journal-title":"Leuk Lymphoma"},{"key":"BF2404320_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1965","unstructured":"Kaplan EL, Meier P . Non-parametric estimation from incomplete observations. J Am Stat Assoc 1965; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BF2404320_CR10","doi-asserted-by":"crossref","first-page":"749a","DOI":"10.1182\/blood.V104.11.749.749","volume":"104","author":"M Vignetti","year":"2004","unstructured":"Vignetti M, Fazi P, Meloni G, Chiarenza A, Malagola A, Fabbiano F et al. Dramatic improvement in CR rate and CR duration with imatinib in adult and elderly Ph+ ALL patients: results of the GIMEMA prospective study LAL0201. Blood 2004; 104: 749a (abstract).","journal-title":"Blood"},{"key":"BF2404320_CR11","doi-asserted-by":"crossref","first-page":"519a","DOI":"10.1182\/blood.V106.11.519.519","volume":"106","author":"H Pfeifer","year":"2005","unstructured":"Pfeifer H, Ottmann OG, Goekbuget N, Wunderle L, Brueck P, Giagounidis A et al. A randomized phase II study of single-agent imatinib versus chemotherapy therapy in elderly patients with Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) including analysis of resistance patterns. Blood 2005; 106: 519a (abstract).","journal-title":"Blood"},{"key":"BF2404320_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood.V99.3.863","volume":"99","author":"L Annino","year":"2002","unstructured":"Annino L, Vegna ML, Camera A, Specchia G, Visani G, Fioritoni G et al. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002; 99: 863\u2013871.","journal-title":"Blood"},{"key":"BF2404320_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1182\/blood-2002-02-0360","volume":"101","author":"UJ Scheuring","year":"2003","unstructured":"Scheuring UJ, Pfeifer H, Wassmann B, Bruck P, Gehrke B, Petershofen EK et al. Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome\/Bcr-Abl-positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571). Blood 2003; 101: 85\u201390.","journal-title":"Blood"},{"key":"BF2404320_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/sj.leu.2403683","volume":"19","author":"F Pane","year":"2005","unstructured":"Pane F, Cimino G, Izzo B, Camera A, Vitale A, Quintarelli C et al. Significant reduction of the hybrid BCR\/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia. Leukemia 2005; 19: 628\u2013635.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404320","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:34:29Z","timestamp":1648784069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,13]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9,1]]}},"alternative-id":["BF2404320"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404320","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,13]]},"assertion":[{"value":"15 April 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}